Dr James Daveson
About
Dr James Daveson is the Director of the Coeliac Disease and Immune Health Research Program at Wesley Research Institute. Dr Daveson is a gastroenterologist with a sub-specialty interest in coeliac disease, with a large patient cohort and strong mature links to coeliac disease support groups.
Over the last 15 years, he has developed an expertise in studies widely recognised as fundamental to the current generation of immune therapies for coeliac disease. His expertise arises from overseeing a large patient cohort in specialised clinics across two sites both in metropolitan and regional Queensland, as well as the Coral Sea Clinical Research Institute.
Dr Daveson completed his medical degree at the University of Queensland and physician training at the Royal Brisbane and Women’s Hospital and Princess Alexandra Hospital. He is an adult gastroenterologist with expertise in luminal gastroenterology, including coeliac disease and inflammatory bowel disease, with an impressive and growing track record as a clinician-researcher in the coeliac disease field. His published work has a high degree of translational relevance and in several instances has directly informed clinical practice.
Qualifications
MBBS (Faculty of Medicine) – University of Queensland
Featured Publications
Daveson, A James M, Stubbs, Richard, Polasek, Thomas M, Isola, Jorma, Anderson, Robert, Tye-Din, Jason A, Schoeman, Mark, Lionnet, Claudette, Mei, Swee Lin Chen Yi, Mihajlović, Jelena, Wirth, Martina, Peelen, Evelyn, Schreieck, Amelie, Kohlhof, Hella, Vitt, Daniel, Muehler, Andreas, and Buriánek, Franziska (2024). Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Gastroenterology & Hepatology 10 (1) 44-54. https://doi.org/10.1016/s2468-1253(24)00248-6
Muir, Richard, Sehgal, Anuj, Tye‐Din, Jason A, and Daveson, A James M (2023). Undiagnosed coeliac disease identified by active case finding in first degree relatives of people with coeliac disease in Australia: a prospective observational study. Medical Journal of Australia 219 (8) 371-373. https://doi.org/10.5694/mja2.52105
Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S., … Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep 2 (1) 22-30. https://doi.org/10.1002/ygh2.380
Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., … Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics 51 (2) 244-252. https://doi.org/10.1111/apt.15551
Goel, Gautam, King, Tim, Daveson, A. James, Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J. E., Fogel, Ronald, Barish, Charles F., Epstein, Roger, Kinney, Timothy P., Miner Jr, Philip B., Girardin, Adam, Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Maki, Makku, Goldstein, Kaela E., Griffin, Patrick H., Wang, Suyue, Dzuris, John L., Williams, Leslie J., Sette, Alessandro, Xavier, Ramnik J., Sollid, Ludvig M., Jabri, Bana, and Anderson, Robert P. (2017). Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology 2 (7) 479-493. https://doi.org/10.1016/S2468-1253(17)30110-3
Links
